Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments
| dc.creator | Goodarzi, Pedram | |
| dc.creator | Mahdavi, Farzad | |
| dc.creator | Mirzaei, Rasoul | |
| dc.creator | Hasanvand, Hamze | |
| dc.creator | Sholeh, Mohammad | |
| dc.creator | Zamani, Farhad | |
| dc.creator | Sohrabi, Masodreza | |
| dc.creator | Tabibzadeh, Alireza | |
| dc.creator | Salimi Jeda, Ali | |
| dc.creator | Karbalaie Niya, Mohammad Hadi | |
| dc.creator | Keyvani, Hossein | |
| dc.creator | Karampoor, Sajad | |
| dc.date.accessioned | 2020-09-01T17:16:19Z | |
| dc.date.available | 2020-09-01T17:16:19Z | |
| dc.date.created | 2020 | |
| dc.description.abstract | The SARS-CoV-2 virus is an etiological agent of pandemic COVID-19, which spreads rapidly worldwide. No proven effective therapies currently exist for this virus, and efforts to develop antiviral strategies for the treatment of COVID-19 are underway. The rapidly increasing understanding of SARS-CoV-2 virology provides a notable number of possible immunological procedures and drug targets. However, gaps remain in our understanding of the pathogenesis of COVID-19. In this review, we describe the latest information in the context of immunological approaches and emerging current antiviral strategies for COVID-19 treatment. | spa |
| dc.format.extent | 13 páginas | spa |
| dc.format.mimetype | image/jepg | spa |
| dc.identifier.doi | https://doi.org/10.1016/j.intimp.2020.106885 | spa |
| dc.identifier.issn | 1567-5769 | spa |
| dc.identifier.other | https://doi.org/10.1016/j.intimp.2020.106885 | spa |
| dc.identifier.uri | https://hdl.handle.net/20.500.12010/12559 | |
| dc.language.iso | eng | spa |
| dc.publisher | International Immunopharmacology | spa |
| dc.rights.accessrights | info:eu-repo/semantics/embargoedAccess | spa |
| dc.rights.local | Acceso restringido | spa |
| dc.source | reponame:Expeditio Repositorio Institucional UJTL | spa |
| dc.source | instname:Universidad de Bogotá Jorge Tadeo Lozano | spa |
| dc.subject | SARS-CoV-2 | spa |
| dc.subject | COVID-19 | spa |
| dc.subject | Drug targets | spa |
| dc.subject | Antiviral strategies | spa |
| dc.subject | Immunological approaches | spa |
| dc.subject.lemb | Síndrome respiratorio agudo grave | spa |
| dc.subject.lemb | COVID-19 | spa |
| dc.subject.lemb | SARS-CoV-2 | spa |
| dc.subject.lemb | Coronavirus | spa |
| dc.title | Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments | spa |
| dc.type.coar | http://purl.org/coar/resource_type/c_2df8fbb1 | spa |
| dc.type.hasversion | info:eu-repo/semantics/acceptedVersion | spa |
| dc.type.local | Artículo | spa |
Archivos
Bloque original
1 - 2 de 2
Cargando...
- Nombre:
- Captura.PNG
- Tamaño:
- 150.39 KB
- Formato:
- Portable Network Graphics
- Descripción:
- Ver portada
Cargando...
- Nombre:
- Coronavirus-disease-2019--COVID-19---Immunological-ap_2020_International-Imm.pdf
- Tamaño:
- 766.5 KB
- Formato:
- Adobe Portable Document Format
- Descripción:
- Artículo reservado
Bloque de licencias
1 - 1 de 1
Cargando...
- Nombre:
- license.txt
- Tamaño:
- 2.87 KB
- Formato:
- Item-specific license agreed upon to submission
- Descripción:
